Jody buys NVS 89.98: Tuesdayâs Top Health Care Stories: Ophthotech, Dendreon, Edwards Lifesciences, and Medtronic
Shares of Ophthotech are up almost 20% this morning in pre-market trading, after signing an agreement with Novartis (NYSE: NVS ) to commercialize its wet AMD (age-related macular degeneration) treatment Fovista outside the U.S. Ophthotech will retain the . ... ...
33 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home